Small fraction of eligible Texas clinicians prescribing lifesaving medications for opioid use disorder

May 13, 2022

Despite scientific evidence that the medication buprenorphine/naloxone (or Suboxone) effectively treats opioid use disorder (OUD), only one-sixth of Texas clinicians surveyed in 2019 and early 2020 said they were prescribing the lifesaving medication, according to a study from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) published May 12 in JAMA Network […]

Photo of blocks spelling Opioid Crisis

Resilient, adaptive, maladaptive responses: an emerging paradigm to explain allergy severity

May 9, 2022

UT Health San Antonio-VA team studies airway lining integrity and inflammation balance in controlled chamber Allergies, including asthma, impose a significant health burden on society. Allergies are the sixth most common cause of chronic illness and are among the top health conditions in children. There is a paradox: Airborne allergens are widespread, yet many people […]

Photo of dandelion with spores

NIH awards $2.4 million grant to UT Health San Antonio and ADA Science & Research Institute to study responsible antibiotic use

April 27, 2022

The National Institutes of Health has awarded a four-year, $2.4 million grant to The University of Texas Health Science Center at San Antonio (UT Health San Antonio), which will work in collaboration with the American Dental Association Science & Research Institute (ADASRI) to conduct a clinical trial studying the responsible use of antibiotics in combination with other treatments for periodontal disease, commonly known as gum disease.



In the race to solve Alzheimer’s disease, scientists find more needles in the haystack

April 20, 2022

Thanks to international collaboration, more genetic variations for Alzheimer’s disease are known today than ever before. The list of gene variants recognized for late-onset Alzheimer’s grew from one in 2009 to 40 in 2022. This month, scientists published a list of 75, some of which are considered as prime drug targets. Drug development is underway.



Team discovers novel drug target for Alzheimer’s and related dementias

April 14, 2022

Researchers from UT Health San Antonio today reported the discovery of a novel mechanism by which pathological forms of tau protein cause neurons to die. Alzheimer’s disease and chronic traumatic encephalopathy (CTE) are among more than 20 disorders that include tau protein pathology. The newly found mechanism of tau-induced damage can be altered pharmacologically, the scientists noted, making it a novel target for drug development.

Photo of a brain made of multicolored wires.